NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Actavis


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Actavis Acquires Kadian; Extends Specialty Drug Portfolio in U.S.
2009 JAN 12 ... Actavis announced that it has acquired the brand name drug Kadian® from King Pharmaceuticals for ...
Subject: Actavis
Price: $3.00
*
Actavis IMS Company Profile
2009 MAR 31 ... has announced the addition of the "Actavis IMS Company Profile" company profile to their offering. IMS ...
Subject: Research and Markets
Price: $3.00
*
Actavis Inc. Reintroduces Oxycodone
2009 MAY 4 ... Actavis Inc. announced the reintroduction by its Actavis Totowa ...
Subject: Actavis Group
Price: $3.00
*
Actavis Receives Approval of Levetiracetam Oral Solution in the U.S.
2009 FEB 3 ... Actavis Group, the international generic pharmaceuticals company, announced that it has received ...
Subject: Actavis Group
Price: $3.00
*
Actavis Totowa and FDA Reach Agreement on Consent Decree
2009 JAN 12 ... Actavis Inc. announced that it has reached agreement on a Consent Decree of Permanent Injunction ...
Subject: Actavis Inc.
Price: $3.00
*
Barr Pharmaceuticals Generics Company Intelligence Report Reveals Teva Pharmaceutical Industries Plan to Acquire Barr in a Deal Worth US$7.46 Billion
2009 JUL 6 ... by the board of the Croatian company. Barr faced strong competition for Pliva from Actavis, although the Icelandic company dropped out of contention after a three month bidding ...
Subject: Research and Markets
Price: $3.00
*
Biopharma Quarter - Key Trends and Events of the First Quarter of 2009
2009 JUL 27 ... most active companies, therapeutic area focus, biologics focus. Generics: Actavis and Ratiopharm up for sale; layoffs announced at key generics companies; the push for ...
Subject: Research and Markets
Price: $3.00
*
Company Profile of Bulgaria's Leading Pharmaceutical Wholesaler: Actavis EAD
2009 JAN 27 ... has announced the addition of the "Actavis EAD (Bulgaria) - Company Profile" company profile to their offering. ...
Subject: Research and Markets
Price: $3.00
*
Digitek Medication Recalled Due to Risk of Digitalis Toxicity
2009 AUG 31 ... (FDA) criticisms of its manufacturing processes, the pharmaceutical company, Actavis Totowa issued a Class I nationwide drug recall for all lots of Digitek (digoxin) on the ...
Subject: Eichen Levinson & Crutchlow, Llp
Price: $3.00
*
Endo and Penwest Announce Settlement of Opana(R) ER Litigation
2009 MAR 9 ... Pharmaceuticals (NASDAQ: PPCO) announced that the companies have settled litigation with Actavis South Atlantic LLC regarding the production and sale of generic formulations of Opana(R) ...
Subject: Pharmaceuticals
Price: $3.00
*
Examine the Antiseptics and Disinfectants World Market
2009 MAR 23 ... CHAPTER TWELVE: COMPANY PROFILES ABC COMPOUNDING CO. ACTAVIS AGION TECHNOLOGIES ALDA PHARMACEUTICAL CORP. ...
Subject: ReportLinker
Price: $3.00
*
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
2009 NOV 9 ... appropriately refused to file the Abbreviated New Drug Application submitted by Actavis Elizabeth, LLC (Actavis) for generic lisdexamfetamine ...
Subject: Shire Plc
Price: $3.00
*
In March 2009, Actavis Announced That It Had Entered the Irish Market with Plans to Create up to 25 New Jobs over the Next Five Years
2009 JUL 6 ... has announced the addition of the "Actavis Generics Company Intelligence Report" company profile to their offering. ...
Subject: Research and Markets
Price: $3.00
*
Italy Pharmaceuticals and Healthcare Report Q2 2009
2009 MAY 25 ... company, sold its Italian manufacturing plant in Nerviano to Icelandic generics company Actavis at the start of 2008, only to announce a major cut in the number of its sales jobs in ...
Subject: Research and Markets
Price: $3.00
*
Q3 2009 Report - Latest Report Examines the German Pharmaceuticals and Healthcare Industry
2009 JUL 20 ... Heumann, Schwarz Pharma, Mylan Dura, AAA Pharma, Basics, Biocon's Axcount, Teva and Actavis are among the drugmakers who have won tenders to provide AOK with medicines. Key Topics ...
Subject: Research and Markets
Price: $3.00
*
Actavis Comments on Filing of DOJ Complaint
2008 DEC 8 ... Actavis, Inc. said that the Department of Justice, on behalf of the Food and Drug Administration ...
Subject: Actavis, Inc.
Price: $3.00
*
Actavis Opens Research and Development Labs in Florida
2008 NOV 17 ... Actavis South Atlantic (ASA), a United States division of the international generic ...
Subject: Actavis Group
Price: $3.00
*
Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion
2008 NOV 10 ... His previous positions at highly reputable organizations such as PPD, Alpharma (Actavis), Solvay Pharmaceuticals and Solvay Animal Health, to name a few, has helped develop his ...
Subject: Biopharmaceuticals
Price: $3.00
*
Studies by B.B. Koleva and co-authors describe new findings in antibiotics
2008 NOV 3 ... for the analysis of 10 tablets of the commercial products Cefamandole and Cefalotin (Actavis) was also studied." Koleva and colleagues published their study in the ...
Subject: Antibiotics
Price: $3.00
*
U.S. Files Suit Against New Jersey Generic Drug Manufacturer That Distributed Adulterated and Misbranded Products
2008 DEC 1 ... The United States is seeking a permanent injunction to bar Actavis Totowa LLC, and Actavis Inc. and two of their officers, ...
Subject: Drug Development
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login